| Document Type
|
:
|
BL
|
| Record Number
|
:
|
1020945
|
| Doc. No
|
:
|
b775315
|
| Title & Author
|
:
|
Angiogenesis inhibitors and stimulators : : potential therapeutic implications /\ Shaker A. Mousa [editor].
|
| Publication Statement
|
:
|
Georgetown, Tex. :: Landes Bioscience ;Austin, Tex. :: Eurekah.com,, ©2000.
|
| Series Statement
|
:
|
Medical intelligence unit ;; 20
|
| Page. NO
|
:
|
1 online resource ([xi], 162 pages) :: illustrations
|
| ISBN
|
:
|
0585415439
|
|
|
:
|
: 1587063441
|
|
|
:
|
: 1597341703
|
|
|
:
|
: 9780585415437
|
|
|
:
|
: 9781587063442
|
|
|
:
|
: 9781597341707
|
|
|
:
|
1587060221
|
|
|
:
|
9781587060229
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references and index.
|
| Contents
|
:
|
Front Cover -- Inside Cover -- Copyright -- Table of Contents -- Editors / Contributors -- Preface -- Chapter 1: Mechanims of Angiogenesis -- Chapter 2: Angiogenisis and Ischemia -- Chapter 3: The Role of Smooth Muscle Cells and Pericytes in Angiogenesis -- Chapter 4: Integrin v in Health and Disease-Role of v3 in Metastasis, Vascular Remodeling and Angiogenesis -- Chapter 5: PECAM-1 and Angiogenesis -- Chapter 6: Thrombospondin and Angiogenesis -- Chapter 7: The Role of Vascular Endothelial Growth Factor in Angiogenesis -- Chapter 8: Regulation of Angiogenesis by Fibroblast Growth Factors.
|
|
|
:
|
Angiogenesis inhibitor -- Antiangiogenesis -- Apoptosis -- Atherosclerosis -- avb3 -- avb5 -- Cancer -- Cell adhesion molecules -- CM-101 123, 145 -- Collateral -- Combinatorial chemical libraries -- Cyclic RGD -- Cytokines -- Cytostatic -- Cytotoxic -- D -- Diabetes -- Diabetic retinopathy -- E -- Endothelial cells -- Endothelial migration -- Extracellular matrix -- F -- FGF 87, -- Fibroblast growth factor (FGF) -- G -- Gene therapy -- Growth factor(s) -- H -- Heparan sulfate -- Hyperoxia 68, 111, 112 -- I -- Imaging -- Immunoglobulin -- Inflammation -- Inflammatory diseases -- Integrins.
|
|
|
:
|
Chapter 9: Role of Angiogenesis in Wound Healing -- Chapter 10: Ocular Neovascularization -- Chapter 11: Anti-Angiogenesis Strategies Potential Therapeutic Implications -- Chapter 12: Matrix Metalloproteinase Inhibitors in Angiogenesis-Mediated Disorders with Special Emphasis on Cancer -- Chapter 13: Pharmaceutical Development of an Antiangiogenic Drug-Candidate -- Chapter 14: Surrogate Endpoints as a Measure of Efficacy in Clinical Trials of Angiogenesis Inhibitors -- Chapter 15: Lessons from Clinical Trials of Anti-Angiogenic Drugs in the Treatment of Cancer -- Index -- A -- Angiogenesis.
|
|
|
:
|
Ischemia -- M -- Macular degeneration -- Matrix -- Matrix metalloproteinases -- Metastasis -- MMP -- N -- Neuropeptide Y -- O -- Ocular disease -- Oncology -- P -- Pericyte -- Plasminogen -- Proliferation -- Proteases -- R -- Remodeling -- Retina -- Revascularization -- S -- Screening -- Signal transduction -- Smooth muscle cell (SMC) -- Surrogate marker -- T -- Tecogalan 11, 145, 153, 155, 157 -- Therapeutic angiogenesis -- Thrombospondin -- Thymosin -- Tube formation -- Tumor angiogenesis -- Tyrosine kinase -- V -- Vascular remodeling -- VEGF -- VEGF receptors -- W -- Wound angiogenesis.
|
| Abstract
|
:
|
The regulation of blood vessel growth underlies many normal biological processes such as reproduction, development, repair and wound healing. It also is a critical feature of pathological processes such as cancer, diabetic retinopathy, macular degeneration, inflammatory arthritis and ischemic heart disease.
|
| Subject
|
:
|
Growth factors.
|
| Subject
|
:
|
Neovascularization inhibitors.
|
| Subject
|
:
|
Neovascularization.
|
| Subject
|
:
|
Angiogenesis Inhibitors-- therapeutic use.
|
| Subject
|
:
|
Growth Substances.
|
| Subject
|
:
|
Neovascularization, Pathologic.
|
| Subject
|
:
|
Growth factors.
|
| Subject
|
:
|
MEDICAL-- Physiology.
|
| Subject
|
:
|
Neovascularization inhibitors.
|
| Subject
|
:
|
Neovascularization.
|
| Subject
|
:
|
SCIENCE-- Life Sciences-- Human Anatomy Physiology.
|
| Dewey Classification
|
:
|
612.1/3
|
| LC Classification
|
:
|
QP106.6.A525 2000eb
|
| NLM classification
|
:
|
QU 107A5876 2000
|
| Added Entry
|
:
|
Mousa, Shaker A.
|